The newly introduced SARS-CoV-2 variant A222V is rapidly spreading in Lazio region, Italy
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
A new SARS-CoV-2 clade (GV) characterized by S substitution A222V, first reported from Spain in March, is rapidly spreading across Europe. To establish the A222V variant involvement in the infection rise in Italy, all GISAID sequences from Italy and those from our Laboratory (Lazio) in the period June-October were analysed. A222V, first recognized in August, represents 11.2% of sequences in this period, reaching 100% of autochthonous sequences in October, supporting increased GV circulation in Italy.
Article activity feed
-
SciScore for 10.1101/2020.11.28.20237016: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources Whole genome sequencing (WGS) was performed on residual respiratory samples by using Ion AmpliSeq™ SARS-CoV-2 research panel on GeneStudio™ S5 Prime System (Thermofisher). WGSsuggested: NoneRaw reads with mean quality Phred score >20 were selected and trimmed using Trimmomatic software v.0.36 [4]. Phredsuggested: (Phred, RRID:SCR_001017)Trimmomaticsuggested: (Trimmomatic, RRID:SCR_011848)SARS-CoV-2 genomes were assembled using reference-based assembly method, with BWA v. BWAsugges…SciScore for 10.1101/2020.11.28.20237016: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources Whole genome sequencing (WGS) was performed on residual respiratory samples by using Ion AmpliSeq™ SARS-CoV-2 research panel on GeneStudio™ S5 Prime System (Thermofisher). WGSsuggested: NoneRaw reads with mean quality Phred score >20 were selected and trimmed using Trimmomatic software v.0.36 [4]. Phredsuggested: (Phred, RRID:SCR_001017)Trimmomaticsuggested: (Trimmomatic, RRID:SCR_011848)SARS-CoV-2 genomes were assembled using reference-based assembly method, with BWA v. BWAsuggested: (BWA, RRID:SCR_010910)0.7.12 [5] and Samtools v. Samtoolssuggested: (SAMTOOLS, RRID:SCR_002105)Assembled contigs were then verified using Geneious 2019.2.3. Geneioussuggested: (Geneious, RRID:SCR_010519)Maximum likelyhood phylogenetic analysis was performed with IQ-TREE v. IQ-TREEsuggested: (IQ-TREE, RRID:SCR_017254)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-